Merit Oncology Expands to Europe, Middle East & Africa (EMEA) to Treat More Patients Globally

Merit Oncology’s newest technology is SCOUT® Radar Localization, an advanced wire-free radar localization system designed to improve the precision and predictability of marking tumors, biopsy sites, and lymph nodes prior to neoadjuvant therapy and surgery. SCOUT Radar Localization is the wire-free platform that exclusively spans the care continuum from biopsy to surgery. Launched in the United States in 2015, more than 885 consoles have been placed, SCOUT has been used in over 180,000 procedures and is supported by over 45 clinical publications.

SCOUT Radar Localization - Preferred Solution to Treat More Patients - Merit Oncology

More Than
930
Consoles

200K
Procedures

60+
Clinical
Publications